Table 3.
Clinical parameters of test and control group (mean ± SD).
| Parameters | Study Group | Baseline † | 4 Weeks ‡ | 8 Weeks ‡ |
|---|---|---|---|---|
| PD | Control | 2.46 ± 0.25 | 2.42 ± 0.26 | 2.42 ± 0.24 |
| Test | 2.58 ± 0.27 | 2.57 ± 0.27 | 2.46 ± 0.34 | |
|
p-value (Test vs. Control) |
0.0618 | 0.1761 | 0.7879 | |
| CAL | Control | 2.57 ± 0.26 | 2.53 ± 0.24 | 2.48 ± 0.25 |
| Test | 2.67 ± 0.27 | 2.64 ± 0.29 | 2.54 ± 0.28 | |
|
p-value (Test vs. Control) |
0.0743 | 0.5005 | 0.5940 | |
| BOP | Control | 41.12 ± 11.20 | 34.44 ± 16.83 | 27.00 ± 13.90 |
| Test | 42.56 ± 12.76 | 31.31 ± 16.95 | 27.65 ± 19.22 | |
|
p-value (Test vs. Control) |
0.6371 | 0.1231 | 0.7272 | |
| GR | Control | 0.38 ± 0.19 | 0.28 ± 0.21 | 0.24 ± 0.19 |
| Test | 0.31 ± 0.15 | 0.22 ± 0.21 | 0.23 ± 0.19 | |
|
p-value (Test vs. Control) |
0.1891 | 0.9078 | 0.5763 | |
| MGI | Control | 0.79 ± 0.22 | 0.66 ± 0.46 | 0.59 ± 0.53 |
| Test | 0.84 ± 0.33 | 0.58 ± 0.46 | 0.50 ± 0.51 | |
|
p-value (Test vs. Control) |
0.8884 | 0.0184 * | 0.0406 * | |
| PI | Control | 0.91 ± 0.31 | 0.78 ± 0.49 | 0.78 ± 0.40 |
| Test | 0.93 ± 0.33 | 0.78 ± 0.48 | 0.66 ± 0.46 | |
|
p-value (Test vs. Control) |
0.9374 | 0.9143 | 0.1354 |
* Statistically significant correlation at p < 0.05. † Obtained from Wilcoxon rank-sum test. ‡ Obtained from generalized linear model adjusted baseline, smoke, age, sex, drink, obesity. PD, probing depth; CAL, clinical attachment loss; BOP, bleeding on probing; GR, gingival recession; MGI, modified gingival index; PI; plaque index.